PharmaCyte Biotech Inc (PMCB)
2.10
-0.02
(-0.94%)
USD |
NASDAQ |
Apr 26, 16:00
2.10
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Price: 2.10 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 2.14 | 2.15 | 2.077 | 2.12 | 14464.00 |
Apr 24, 2024 | 2.15 | 2.20 | 2.12 | 2.20 | 12340.00 |
Apr 23, 2024 | 2.15 | 2.18 | 2.13 | 2.13 | 1645.00 |
Apr 22, 2024 | 2.122 | 2.28 | 2.122 | 2.22 | 8046.00 |
Apr 19, 2024 | 2.12 | 2.20 | 2.11 | 2.12 | 10642.00 |
Apr 18, 2024 | 2.07 | 2.31 | 2.07 | 2.20 | 5886.00 |
Apr 17, 2024 | 2.12 | 2.31 | 2.12 | 2.12 | 8821.00 |
Apr 16, 2024 | 2.11 | 2.16 | 2.07 | 2.15 | 12303.00 |
Apr 15, 2024 | 2.18 | 2.39 | 2.11 | 2.11 | 26471.00 |
Apr 12, 2024 | 2.27 | 2.46 | 2.23 | 2.23 | 38104.00 |
Apr 11, 2024 | 2.23 | 2.40 | 2.23 | 2.30 | 33629.00 |
Apr 10, 2024 | 2.23 | 2.293 | 2.23 | 2.26 | 8938.00 |
Apr 09, 2024 | 2.36 | 2.379 | 2.30 | 2.30 | 19663.00 |
Apr 08, 2024 | 2.40 | 2.45 | 2.310 | 2.39 | 15781.00 |
Apr 05, 2024 | 2.459 | 2.50 | 2.42 | 2.42 | 12120.00 |
Apr 04, 2024 | 2.55 | 2.55 | 2.460 | 2.52 | 13059.00 |
Apr 03, 2024 | 2.445 | 2.54 | 2.445 | 2.51 | 29095.00 |
Apr 02, 2024 | 2.425 | 2.50 | 2.421 | 2.48 | 51066.00 |
Apr 01, 2024 | 2.36 | 2.445 | 2.36 | 2.445 | 20010.00 |
Mar 28, 2024 | 2.42 | 2.50 | 2.29 | 2.37 | 34542.00 |
Mar 27, 2024 | 2.340 | 2.58 | 2.340 | 2.44 | 14826.00 |
Mar 26, 2024 | 2.56 | 2.56 | 2.34 | 2.44 | 345490.0 |
Mar 25, 2024 | 2.45 | 2.539 | 2.45 | 2.48 | 56029.00 |
Mar 22, 2024 | 2.45 | 2.45 | 2.34 | 2.44 | 40276.00 |
Mar 21, 2024 | 2.35 | 2.50 | 2.34 | 2.41 | 52991.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.91
Minimum
Feb 24 2022
85.35
Maximum
Jan 27 2020
18.76
Average
3.10
Median
Oct 13 2021
Price Benchmarks
CEL-SCI Corp | 1.43 |
AIM ImmunoTech Inc | 0.424 |
IGC Pharma Inc | 0.447 |
NovaBay Pharmaceuticals Inc | 0.0781 |
Protalix BioTherapeutics Inc | 1.15 |
Price Related Metrics
PS Ratio | 629.18 |
Price to Book Value | 0.5666 |
Earnings Yield | -57.14% |
Market Cap | 17.78M |